Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy Q Cron

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis Care & Research|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis Care & Research|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
The Journal of Rheumatology|April 17, 2015
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisFrancesca Minoia, Sergio Davì, AnnaCarin Horne, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2014
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisSergio Davì, Francesca Minoia, Angela Pistorio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2018
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive DiseaseDaniel J Lovell, Anne L Johnson, Bin Huang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of TherapyClaas H Hinze, Dirk Foell, Anne L Johnson, et al.
Annals of the Rheumatic Diseases|September 29, 2019
Emergent high fatality lung disease in systemic juvenile arthritisVivian E Saper, Guangbo Chen, Gail H Deutsch, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis Care & Research|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis Care & Research|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
The Journal of Rheumatology|April 17, 2015
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisFrancesca Minoia, Sergio Davì, AnnaCarin Horne, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2014
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisSergio Davì, Francesca Minoia, Angela Pistorio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2018
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive DiseaseDaniel J Lovell, Anne L Johnson, Bin Huang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of TherapyClaas H Hinze, Dirk Foell, Anne L Johnson, et al.
Annals of the Rheumatic Diseases|September 29, 2019
Emergent high fatality lung disease in systemic juvenile arthritisVivian E Saper, Guangbo Chen, Gail H Deutsch, et al.
Pageof 19